$0.00
Retatrutide is a next-generation synthetic peptide designed to activate three receptors simultaneously — GLP-1, GIP, and glucagon — offering a unique multi-pathway approach to metabolic balance.
What it’s used for:
Under investigation for its powerful potential to reduce body fat, improve insulin sensitivity, and support healthy glucose metabolism.
Benefits:
Possible Side Effects:
FDA Status:
Not yet FDA approved. Currently in Phase 3 clinical trials for obesity and metabolic conditions.
FDA Registration: Not available at this stage.
Disclaimer:
IMPORTANT NOTICE: The buyer is responsible for their own research. Vanguard BioLabs does not provide dosage guidelines or application instructions. This product is sold for research purposes only.
Disclaimer – Research Use Only
All information provided is strictly for research purposes. The peptides offered are intended solely for scientific study by qualified professionals. They are not for human use, medical, veterinary, or household purposes. This content does not constitute medical or legal advice, nor does it endorse any non-research application. Products must be reconstituted with bacteriostatic water and handled responsibly. Use is governed by our Terms & Conditions.
